Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
19.04 AUD | -0.13% | -1.37% | -23.77% |
04-24 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
04-23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
Sales 2024 * | 154M 100M 138M | Sales 2025 * | 174M 113M 156M | Capitalization | 2.43B 1.59B 2.18B |
---|---|---|---|---|---|
Net income 2024 * | 92M 60.03M 82.41M | Net income 2025 * | 96M 62.64M 85.99M | EV / Sales 2024 * | 14.3 x |
Net cash position 2024 * | 236M 154M 211M | Net cash position 2025 * | 344M 225M 309M | EV / Sales 2025 * | 12 x |
P/E ratio 2024 * |
26.2
x | P/E ratio 2025 * |
25.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.53% |
Latest transcript on Neuren Pharmaceuticals Limited
1 day | -0.13% | ||
1 week | -1.37% | ||
Current month | -10.30% | ||
1 month | -11.51% | ||
3 months | -20.72% | ||
6 months | +82.50% | ||
Current year | -23.77% |
Managers | Title | Age | Since |
---|---|---|---|
Jon Pilcher
CEO | Chief Executive Officer | 58 | 13-08-18 |
Lauren Frazer
DFI | Director of Finance/CFO | - | 20-07-31 |
Liza Squires
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 02-03-04 | |
Dianne Angus
BRD | Director/Board Member | 63 | 18-07-04 |
Jenny Lee Harry
BRD | Director/Board Member | - | 18-07-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 773 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 34 M€ | +1.32% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 19.04 | -0.13% | 21 945 |
24-05-01 | 19.06 | -0.73% | 442,875 |
24-04-30 | 19.2 | -0.26% | 216,296 |
24-04-29 | 19.25 | +3.22% | 366,543 |
24-04-26 | 18.65 | -1.06% | 566,651 |
Delayed Quote Australian S.E., May 01, 2024 at 08:26 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.77% | 1.59B | |
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |
- Stock Market
- Equities
- NEU Stock